Axalta Coating Systems (AXTA) Q3 2024 earnings summary

Executive summary

• Achieved record third-quarter net sales of $1.32 billion, marking the 15th consecutive quarter of year-over-year growth, driven by the CoverFlexx acquisition, share gains, and volume growth despite macroeconomic headwinds.

• Adjusted EBITDA reached a record $291 million, up 12% year-over-year, with margin expanding 220 basis points to 22.1%.

• Net income rose 40% year-over-year to $102 million, with adjusted diluted EPS up 31% to $0.59.

• Transformation actions and cost reductions contributed to margin expansion and operational efficiency.

• Launched new products and completed the CoverFlexx acquisition, supporting growth in the economy segment.

Financial highlights

• Net sales increased by 1% year-over-year to $1.32 billion in Q3, with nine-month net sales up 2% to $3,965 million, primarily from acquisitions and higher volumes.

• Adjusted EBITDA for Q3 was $291 million (22.1% margin); nine-month Adjusted EBITDA was $841 million, up from $701 million year-over-year.

• Net income for Q3 was $102 million; nine-month net income attributable to common shareholders was $254 million.

• Gross margin improved by 270 basis points to 35% in Q3, supported by lower variable costs and productivity gains.

• Cash and cash equivalents at quarter end were $567 million; total liquidity exceeded $1.2 billion.

Outlook and guidance

• Raised full-year 2024 guidance: net sales ~$5.275 billion, adjusted EBITDA ~$1.115 billion, adjusted diluted EPS ~$2.15, and free cash flow ~$500 million.

• Transformation Initiative expected to deliver $10 million in run-rate savings in 2024, $30–40 million incremental benefit in 2025, and $75 million annualized savings by 2026.

• Net sales expected to be up $100 million versus 2023; macro trends expected to remain soft in early 2025.

• Capex for the full year expected to be ~$210 million; tax rate (as adjusted) ~25%.

• 2026 A Plan targets: >$500 million net sales growth, >21% Adjusted EBITDA margin, net leverage 2.0x–2.5x, >60% Adjusted diluted EPS growth vs. 2023.